The FDA advisory panel recommends the use of the Moderna COVID-19 vaccine


The second coronavirus vaccine is near a step in the hands of Americans. An advisory panel voted Thursday to recommend that the Food and Drug Administration authorize the modern vaccine for emergency use, as they did last week for the Pfizer vaccine.

Members of the Vaccine and Related Biological Products Advisory Committee voted 20-0 with one exception in favor of the vaccine.

The FDA is expected to quickly authorize the immediate use of the vaccine in the fight against COVD-19, which means it could begin administering it as early as next week.

The panel’s opinion suggests that members believe that given the completeness of the scientific evidence, the benefits outweigh the risks for people 18 and older.

A member of the panel was the president and CEO of Mehri Medical College in Nashville, Tennessee. James Hildreth said it was a “significant achievement” to have two vaccines available in December, as the virus was in its infancy in January.

The committee, which provides advice to the agency, Last week Offers thumbs up for a vaccine developed by Pfizer and Bioentech. The next day the FDA authorized it. Health care workers and other priority recipients began He received the vaccine on Monday What would be the largest vaccination program in the history of the country.

“The well-studied evidence about this vaccine is far superior to any of the issues we’ve seen and it is able to put an epidemic in our background, really move forward and ultimately provide a safe and effective way.” “Dr. Hale Gains, a pediatrician and professor of pediatrics at Stanford University Medical Center, said.

Moder’s vaccine is said to have the same 94% effectiveness as Pfizer. But unlike the Pfizer vaccine, which must be shipped and stored Extremely cold temperatures, Moderna can be kept at a standard freezer temperature. Both vaccines are required Two doses; The second dose of Pfizer vaccine must be given 21 days after the first, while 28 days after Moderna.


The doctor answers questions about COVID vaccines

02:17

According to data compiled by Johns Hopkins University, U.S. There have been more than 1,17.1 million confirmed cases of Covid-1 in India, and 10,10,000 people have died from the virus since the outbreak began earlier this year. Amid a nationwide increase in the week following Thanksgiving holiday weekend, more than 30,000 deaths and more than 777,000 new cases were reported on Wednesday. The last week has seen a nearly 10% increase in cases, while states like Maine have seen a 20% increase and New Hampshire a 21.2% increase.

Yet, two health care workers in Alaska Allergic reaction report For the Pfizer vaccine.

.